No Prescription |
 |
 | ||
|
Atrovent Inhaler Generic Ipratropium bromide |
|
| ||
No Prescription » Prescription Drugs 2 » Atrovent Inhaler Generic Ipratropium bromide Ipratropium is used to treat lung diseases such as chronic bronchitis and emphysema. It relaxes the muscles around your airways so that they open up and you breathe more easily. This medication is a type of bronchodilator.Use your quick-relief inhaler or nebulized solution (e.g. albuterol) for acute attacks of shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief treatment and in general is not used alone to relieve an acute attack but if so prescribed by your doctor you may use it together with albuterol.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication may also be used in combination with other drugs to treat asthma in select patients.How to use Atrovent InhlRead the Patient Information Leaflet that comes with this medication and the instructions for how to use the nebulization equipment. A healthcare professional will teach you the proper way to measure out the medication and use the machine. Consult your healthcare professional if you have any questions.Inhale this medication into your lungs using the nebulizer usually 3 or 4 times a day (6 or 8 hours apart) or as directed by your doctor. It is recommended that you use a mouthpiece rather than a face mask with the nebulizer or that you close your eyes during use to avoid getting any medication into your eyes. This will minimize the risk of temporary blurred vision other vision changes and eye irritation.Ipratropium may be mixed with other prescribed medications such as albuterol or metaproterenol in the nebulizer and used within 1 hour of mixing. If this medication is mixed with saline use immediately. Check with your doctor or pharmacist before mixing any other medications. Once a vial is opened throw away any remaining unused solution.Each treatment should last about 5-15 minutes. Rinse your mouth after treatment to prevent dry mouth and throat irritation. Clean the nebulizer according to the manufacturer's directions.If you are directed to take this medication regularly it works best if used consistently at evenly spaced intervals. Remember to use it at the same times each day. Do not increase your dose use it more frequently or stop using this medication without first consulting your doctor. Dosage is based on your medical condition and response to therapy.Be sure you understand which of your inhalers and nebulized solutions you should use on a regular daily basis and which you should use for acute attacks. Consult your doctor about what you should do in case of worsening shortness of breath or cough increased sputum or worsening peak flow meter readings (whether you can self-medicate and when you must seek immediate medical attention). Buy Atrovent Inhaler Generic Ipratropium bromide and other Prescription Drugs 2 products online at Medstore. 5099
About Atrovent Inhaler Generic Ipratropium bromide: Product Type: Prescription Drugs 2 Atrovent Inhaler ( Generic Ipratropium bromide ) Atrovent Inhaler (Generic Ipratropium bromide) Generic Ipratropium bromide 20mcg 200 MD Generic Ipratropium bromide Atrovent Inhaler
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
